发明名称 LYOPHILIZED PHARMACEUTICAL COMPOSITIONS
摘要 <p>Pharmaceutical compositions that include a poorly water-soluble therapeutic compound, an aqueous solvent, an chelator/antioxidant, a buffer or buffer component, and a bulking agent. The pharmaceutical compositions can be orally ingested or administered parenterally. The pharmaceutical compositions can further be lyophilized to form a pharmaceutically acceptable cake that can be administered orally, e.g., as a solid oral dosage form; or reconstituted and administered parenterally, e.g. as a single i.v. bolus or iv infusion, or administered orally, e.g. as a drink solution.</p>
申请公布号 WO2009039226(A1) 申请公布日期 2009.03.26
申请号 WO2008US76752 申请日期 2008.09.18
申请人 NOVARTIS AG;BURANACHOKPAISAN, THITIWAN;JIANG, WENLEI;TONG, WEI-QIN;ZIELINSKI, JOSEPH, LAWRENCE;ZHU, JIAHAO;ZOBEL, HANS-PETER 发明人 BURANACHOKPAISAN, THITIWAN;JIANG, WENLEI;TONG, WEI-QIN;ZIELINSKI, JOSEPH, LAWRENCE;ZHU, JIAHAO;ZOBEL, HANS-PETER
分类号 A61K9/19;A61K31/4045;A61K47/02;A61K47/12;A61K47/18;A61K47/26;A61K47/36;A61K47/40 主分类号 A61K9/19
代理机构 代理人
主权项
地址